HP Inc. announced that its Board of Directors has expanded to 15 members with the election of Gianluca Pettiti as a new director. Pettiti, who is Executive Vice President and President of Life Sciences, Diagnostics, and Applied at Thermo Fisher Scientific Inc., has been deemed an independent director under NYSE listing standards. He will serve on the Finance, Investment, and Technology Committee, as well as the HR and Compensation Committee.

Pettiti will receive compensation consistent with other non-employee directors, including an annual cash retainer of $105,000 (which can be taken as equity), an annual equity grant of $220,000, and additional compensation for excess board and committee meetings. His first-year compensation will be prorated.

Additionally, the Board amended HP’s bylaws to formally increase the number of directorships from 14 to 15, reflecting Pettiti’s appointment. The amendments took effect on February 21, 2025.